Postoperative Complications Do Not Differ With Obesity in Ankle Arthroplasty
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 25, 2023 -- For patients undergoing total ankle arthroplasty (TAA), the impact of obesity on outcomes is unclear, according to two studies recently published in Foot & Ankle International.
Billy I. Kim, from Duke University in Durham, North Carolina, and colleagues conducted a single-institution, retrospective study of 1,093 primary TAA performed between 2001 and 2020 with minimum follow-up for two years. Patients were stratified by body mass index (BMI) into control, obesity class I, and obesity class II (BMI, 18.5 to 29.9, 30.0 to 34.9, and >35.0 kg/m2 [615, 285, and 193 patients, respectively]). The researchers found that across BMI classes, there were no statistically significant differences in postoperative complications (infection, implant failure, or impingement).
Toby Jennison, M.B.B.S., Ph.D., from the University Hospitals Plymouth NHS Trust in the United Kingdom, and colleagues conducted a data linkage study combining the National Joint Registry Data and National Health Service Digital data to assess the risk factors for failure of total ankle replacements. The researchers found that the overall five-year survival was 90.2 percent. Only age, body mass index, and underlying etiology were associated with an increased risk for failure in multivariable models (hazard ratios, 0.96, 1.03, and 0.88, respectively).
"The fact that there continues to be conflicting information in the literature regarding the impact of BMI on total ankle replacement outcomes suggests that there are factors at play that are not easily identified or assessed," Timothy R. Daniels, M.D., and Ellie Pinsker, Ph.D., both from the University of Toronto, write in an accompanying editorial.
One editorial author disclosed ties to Smith & Nephew.
Abstract/Full Text - Kim (subscription or payment may be required)
Abstract/Full Text - Jennison (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.